Algeta ASA (OSL:ALGETA) Algeta Reports Results For The Third Quarter 2008
Algeta ASA (OSL:ALGETA) Alpharadin - Phase III ALSYMPCA study in hormone-refractory prostate cancer patients now enrolling
Algeta ASA (OSL:ALGETA) Alpharadin - Phase III ALSYMPCA study in hormone-refractory prostate cancer patients now enrolling
ELMOS Semiconductor AG (OJ:ELG) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
ELMOS Semiconductor AG (OJ:ELG) ELMOS Semiconductor AG / Interim report, Quarterly report / Ad hoc: ELMOS: Declining sales in third quarter 2008 due to car manufacturer crisis Ad hoc announcement according to §15 WpHG processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
Incap Oyj (HEL:ICP1V) Incap Corporation Stock Exchange Release 5 November 2008 at 8:30 a.m.
Cermaq ASA (OSL:CEQ) (Oslo 05.11.2008) Cermaq reported EBIT pre fair value of NOK 164.1 million for Q3, a reduction of NOK 50.8 million from 2007. Good biological performance and increased prices gave good results in farming in Norway and in Canada and strengthened the result with approximately NOK 31 million vs. 2007. This was however not enough to offset the losses in farming in Chile and reduced margin for EWOS.
Hannover Rück (FRA:HNR1) Capital market crisis and above-average volume of catastrophe losses dominant factors in the result as at 30 September 2008
KappAhl (STO:KAHL) The Annual Report of KappAhl for 2007/2008 in Swedish is published today at www.kappahl.com/ir. The annual report in English will be available from November 11 2008.